33.950
-1.050
(-3.00%)
At close: January 28 at 12:08:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-712,004.000
-726,077.000
-653,915.000
-604,679.000
-609,956.000
Investing Cash Flow
-44,582.000
21,922.000
-384,612.000
-466,522.000
-107,367.000
Financing Cash Flow
310,023.000
368,751.000
619,268.000
1,781,387.000
1,040,003.000
End Cash Position
943,428.000
1,038,048.000
1,345,639.000
1,706,886.000
1,019,979.000
Capital Expenditure
-38,588.000
-56,844.000
-236,963.000
-436,629.000
-251,476.000
Issuance of Capital Stock
533,945.000
470,089.000
19.000
1,300,645.000
634,217.000
Issuance of Debt
209,417.000
953,500.000
763,617.000
599,737.000
527,805.000
Repayment of Debt
-339,884.000
-956,091.000
-54,504.000
-51,150.000
-95,000.000
Repurchase of Capital Stock
-7,882.000
-5,923.000
-26,776.000
-25,874.000
--
Free Cash Flow
-750,592.000
-782,921.000
-890,878.000
-1,041,308.000
-861,432.000
12/31/2020 - 10/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1530.HK 3SBIO
6.010
-3.22%
9926.HK Akeso, Inc.
60.850
+1.76%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
159.300
-0.62%
9688.HK Zai Lab Limited
20.900
+1.95%
1801.HK INNOVENT BIO
33.050
+0.15%
9969.HK InnoCare Pharma Limited
5.530
-2.81%
145020.KQ Hugel, Inc.
237,500.00
+2.81%
AKESF Akeso, Inc.
7.10
0.00%
6996.HK Antengene Corporation Limited
0.780
-1.27%
1877.HK JUNSHI BIO
11.000
-2.83%